LV: Clinical Trials

27 trials of LV, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

23 completed, 1 recruiting, 1 terminated, 1 unknown. 27 Phase 1, 5 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 127Completed 23, Recruiting 1, Terminated 1, Unknown 1, Withdrawn 1
Phase 25Completed 3, Recruiting 1, Withdrawn 1

Follow LV: new trials by email Literature Review of LV trials Research Report on LV

Trials (filtered) newest first · largest first

All 27 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Liposomal Irinotecan + Oxaliplatin + Bevacizumab Versus Liposomal Irinotecan + 5-FU/LV
Irinotecan liposoma, oxaliplatin, bevacizumab - Advanced Pancreatic Cancer (Part 1)
Phase 1 / Phase 2RecruitingDai, Guanghai1382024-06-232025-01-20
Dose Escalation and Expansion Clinical Trial of Irinotecan Liposome Combined With Oxaliplatin and 5-FU/LV Plus Bevacizumab as First-line Treatment of Metastatic Colorectal Cancer
Irinotecan Liposome, Oxaliplatin, 5-FU - Metastatic Colorectal Cancer
Phase 1UnknownShanghai Zhongshan Hospital782024-03-112024-03-19
Biweekly SOLAR, as First-line C/T in Pts With Gastric, Pancreatic and Biliary Cancers
Oxaliplatin, Albumin-Bound Paclitaxel /nab-Paclitaxel, S-1 - Gastric Cancer in Situ, Pancreatic Cancers
Phase 1CompletedNational Health Research Institutes, Taiwan182018-06-262022-04-07
Safety and Efficacy of SGN-LIV1A Plus Pembrolizumab for Patients With Locally-Advanced or Metastatic Triple-Negative Breast Cancer
ladiratuzumab vedotin, Pembrolizumab - Triple Negative Breast Neoplasms
Phase 1 / Phase 2CompletedSeagen Inc.1852018-02-272025-12-12
Carfilzomib and Hyper-CVAD in Treating Patients With Newly Diagnosed Acute Lymphoblastic Leukemia or Lymphoma
carfilzomib, cyclophosphamide, vincristine sulfate - Contiguous Stage II Adult Lymphoblastic Lymphoma, Noncontiguous Stage II Adult Lymphoblastic Lymphoma
Phase 1CompletedMehrdad Abedi, MD102015-12-172022-03-10
C-Met Inhibitor AMG 337, Oxaliplatin, Leucovorin Calcium, and Fluorouracil in Treating Patients With Advanced Stomach or Esophageal Cancer
c-Met inhibitor AMG 337, placebo, oxaliplatin - Adenocarcinoma of the Esophagus, Adenocarcinoma of the Gastroesophageal Junction
Phase 1 / Phase 2WithdrawnEastern Cooperative Oncology Group2015-03-062023-05-25
Genetically Modified Neural Stem Cells, Flucytosine, and Leucovorin for Treating Patients With Recurrent High-Grade Gliomas
E. coli CD-expressing genetically modified neural stem cells, flucytosine, leucovorin calcium - Adult Anaplastic Astrocytoma, Adult Anaplastic Oligodendroglioma
Phase 1CompletedCity of Hope Medical Center162014-10-282026-11-03
MEK Inhibitor MEK162 in Combination With Leucovorin Calcium, Fluorouracil, and Oxaliplatin in Treating Patients With Advanced Metastatic Colorectal Cancer
MEK inhibitor MEK162, leucovorin calcium, fluorouracil - Recurrent Colon Cancer, Recurrent Rectal Cancer
Phase 1CompletedCity of Hope Medical Center262014-07-162026-10-19
A Safety Study of SGN-LIV1A in Breast Cancer Patients
ladiratuzumab vedotin, Trastuzumab - HER2 Positive Breast Neoplasms, Hormone Receptor Positive Breast Neoplasms
Phase 1CompletedSeagen Inc.2902013-10-222023-03-07
CPI-613 and Combination Chemotherapy in Treating Patients With Metastatic Pancreatic Cancer
6,8-bis(benzylthio)octanoic acid, oxaliplatin, leucovorin calcium - Acinar Cell Adenocarcinoma of the Pancreas, Duct Cell Adenocarcinoma of the Pancreas
Phase 1CompletedWake Forest University Health Sciences212013-04-012023-07-12
FOLFIRINOX Plus PF-04136309 in Patients With Borderline Resectable and Locally Advanced Pancreatic Adenocarcinoma
Oxaliplatin, Irinotecan, Leucovorin - Pancreatic Neoplasms
Phase 1CompletedWashington University School of Medicine442012-04-012016-09-19
Genotype-guided Dosing of mFOLFIRINOX Chemotherapy in Patients With Previously Untreated Advanced Gastrointestinal Malignancies
oxaliplatin, irinotecan hydrochloride, leucovorin calcium - Acinar Cell Adenocarcinoma of the Pancreas, Adenocarcinoma of the Gallbladder
Phase 1CompletedUniversity of Chicago792012-03-262020-05-08
Everolimus and Combination Chemotherapy in Treating Patients With Metastatic Stomach or Esophageal Cancer
fluorouracil, leucovorin calcium, oxaliplatin - Adenocarcinoma of the Esophagus, Adenocarcinoma of the Gastroesophageal Junction
Phase 1 / Phase 2CompletedCity of Hope Medical Center62012-02-012017-05-31
Radiolabeled Monoclonal Antibody Therapy, Combination Chemotherapy, and Bevacizumab in Treating Patients With Metastatic Colorectal Cancer
irinotecan hydrochloride, leucovorin calcium, fluorouracil - Recurrent Colon Cancer, Recurrent Rectal Cancer
Phase 1CompletedCity of Hope Medical Center32011-08-302026-10-16
Panobinostat and Fluorouracil Followed By Leucovorin Calcium in Treating Patients With Stage IV Colorectal Cancer Who Did Not Respond to Previous Fluorouracil-Based Chemotherapy
panobinostat, fluorouracil, leucovorin calcium - Recurrent Colon Cancer, Recurrent Rectal Cancer
Phase 1TerminatedUniversity of Southern California72010-10-012015-05-27
Stereotactic Radiation, Nelfinavir Mesylate & Neoadjuvant Chemotherapy in Locally Advanced Pancreatic Cancer
gemcitabine hydrochloride, leucovorin calcium, fluorouracil - Adenocarcinoma of the Pancreas, Stage III Pancreatic Cancer
Phase 1CompletedUniversity of Nebraska462007-11-052023-10-10
A Study of PEP02 in Combination With 5-fluorouracil (5-FU) and Leucovorin (LV) in Advanced Solid Tumors
PEP02, 5-FU, LV - Solid Tumor
Phase 1CompletedPharmaEngine162006-01-012016-08-30
Combination Chemotherapy in Treating Young Patients With Advanced Solid Tumors
oxaliplatin, fluorouracil, leucovorin calcium - Childhood Central Nervous System Choriocarcinoma, Childhood Central Nervous System Embryonal Tumor
Phase 1CompletedNational Cancer Institute (NCI)422005-09-012013-05-03
Suberoylanilide Hydroxamic Acid, Fluorouracil, Leucovorin, and Oxaliplatin in Treating Patients With Progressive Metastatic or Unresectable Colorectal Cancer or Other Solid Tumors
oxaliplatin, leucovorin calcium, vorinostat - Recurrent Colon Cancer, Recurrent Rectal Cancer
Phase 1CompletedNational Cancer Institute (NCI)542005-07-012013-09-30
Chemoimmunotherapy With Epratuzumab in Relapsed Acute Lymphoblastic Leukemia (ALL)
L-asparaginase, doxorubicin hydrochloride, therapeutic hydrocortisone - Recurrent Childhood Acute Lymphoblastic Leukemia
Phase 1 / Phase 2CompletedChildren's Oncology Group1342005-02-012017-12-12

Showing 20 of 27. Sign in to see all of them.

Conditions studied

Rectal Neoplasms (7)  ·  Colonic Neoplasms (6)  ·  Pancreatic Neoplasms (5)  ·  Stomach Neoplasms (3)  ·  Adenocarcinoma Of Esophagus (2)  ·  Esophageal Neoplasms (2)  ·  Precursor Cell Lymphoblastic Leukemia-Lymphoma (2)  ·  Triple Negative Breast Neoplasms (2)  ·  Astrocytoma (1)  ·  Bile Duct Neoplasms (1)  ·  Biliary Tract Neoplasms (1)  ·  Brain Neoplasms (1)  ·  Breast Neoplasms (1)  ·  Colorectal Neoplasms (1)  ·  Gallbladder Neoplasms (1)

Sponsors

National Cancer Institute (NCI) (9)  ·  City of Hope Medical Center (4)  ·  Seagen Inc. (2)  ·  Children's Oncology Group (1)  ·  Dai, Guanghai (1)  ·  Eastern Cooperative Oncology Group (1)  ·  Mehrdad Abedi, MD (1)  ·  National Health Research Institutes, Taiwan (1)  ·  PharmaEngine (1)  ·  Shanghai Zhongshan Hospital (1)  ·  University of Chicago (1)  ·  University of Nebraska (1)  ·  University of Southern California (1)  ·  Wake Forest University Health Sciences (1)  ·  Washington University School of Medicine (1)

Countries

United States (23)  ·  China (2)  ·  Australia (1)  ·  Canada (1)  ·  Germany (1)  ·  Puerto Rico (1)  ·  South Korea (1)  ·  Spain (1)  ·  Taiwan (1)

Top investigators

Heinz-Josef Lenz (2)  ·  Marwan Fakih (2)  ·  Zejing Wang, MD, PhD (2)  ·  Andrea Wang-Gillam, M.D., PhD (1)  ·  Brandon Croft, PharmD (1)  ·  Caio Rocha Lima, MD (1)  ·  Chi Lin (1)  ·  Daniel Haller (1)  ·  Elizabeth Raetz, MD (1)  ·  Gary K. Schwartz (1)  ·  Gary Schwartz (1)  ·  George Wilding (1)  ·  Hedy Kindler (1)  ·  Jana Portnow (1)  ·  Jeffrey Wong, MD (1)

Results publications

PMID 27055731, PMID 27871319, PMID 28495639, PMID 30825970, PMID 37678921, PMID 38902994

NIH funding

U01CA069856 (2), 2017 (1), P30CA012197 (1), P30CA036727 (1), U01CA062491 (1), U01CA062505 (1), U01CA070095 (1), U10CA021115 (1), U10CA098543 (1), U10CA180820 (1)